High response rates seen in phase-III trial of chemotherapy, new drug and stem cells in myeloma
Tuesday, October 12, 2010 - 09:31
in Health & Medicine
The first study of its kind comparing two different approaches to treating newly diagnosed multiple myeloma has found that both treatments achieved a positive response, researchers said at the 35th Congress of the European Society for Medical Oncology (ESMO) in Milan, Italy.